Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 820-830

  Hamada, Katsuyuki ^a   Shirakawa, Toshiro ^b   Gotoh, Akinobu ^c   Roth, Jack A ^d   Follen, Michele ^d  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gunma Univetsity   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Antisense; Apoptosis; Cervical cancer; E6; E7; HPV 16; Recombinant adenovirus

Indexed keywords

COMPLEMENTARY RNA; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; TUMOR GROWTH; UTERINE CERVIX CANCER; VIRAL GENE THERAPY; VIRUS INFECTION; VIRUS INHIBITION; WART VIRUS;

ADENOVIRIDAE; APOPTOSIS; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS; RNA, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 33751404361     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.06.035     Document Type: Article

References (41)

1. Brinton L.A. The epidemiology of human papillomavirus and cervical cancer. In: Munoz N., Bosch F., Shah K.Y., and Meheus A. (Eds). IARC Sci Publ: Lyon vol. 119 (1992) 3-23
2. Mitchell M.F., Hittelman W.K., Lotan R., Nishioka K., Tortolero-Luna G., Richards-Kortum R., et al. Chemoprevention trials and surrogate end point biomarkers in the cervix. Cancer 76 (1995) 1956-1977
3. Durst M., Gissmann L., Ikenberg H., and zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 3812-3815
4. Steele C., and Shillitoe E.J. Viruses and oral cancer. Crit. Rev. Oral Biol. Med. 2 (1991) 153-175
5. Scheffner M., Huibregtse M.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 (1993) 495-505
6. Fujita M., Inoue M., Tanizawa O., Iwamoto S., and Enomoto T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papilloma infection. Cancer Res. 52 (1992) 5323-5328
7. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
8. Kaur P., McDougall J.K., and Cone R. Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. J. Gen. Virol. 70 (1989) 1261-1266
9. Howley P.M., Scheffner M., and Münger K. Oncoproteins encoded by the cancer-associated human papillomavirus target the products of the retinoblastoma and p53 tumor suppressor genes. Cold Spring Harbor Symp. Quant. Biol. 56 (1991) 149-155
10. Crook T., Morgenstern J.P., Crawford L., and Banks L. Continued expression of HPV 16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J. 8 (1989) 513-519
11. Watanabe S., Kanda T., and Yoshiike K. Growth dependence of human papillomavirus 16 DNA-positive cervical cancer cell lines and human papillomavirus 16-transformed human and rat cells on the viral oncoproteins. Jpn. J. Cancer Res. 84 (1993) 1043-1049
12. Inouye M. Antisense RNA: its functions and applications in gene regulation-A review. Gene 72 (1988) 25-34
13. Crooke S.T. Therapeutic applications of oligonucleotides. Biotechnology 10 (1992) 882-886
14. Stein C.A., and Cheng Y.C. Antisense oligonucleotides as therapeutic agents-Is the bullet really magical?. Science 261 (1993) 1004-1012
15. von Knebel Doeberitz M., Oltersford T., Schwarz E., and Gissmann L. Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-I cervical carcinoma cells. Cancer Res. 48 (1988) 3780-3786
16. Steele C., Sacks P.G., Adler-Storthz K., and Shillitoe E.J. Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18. Cancer Res. 52 (1992) 4706-4711
17. Steele C., Cowsert L.M., and Shillitoe E.J. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res. 53 (1993) 2330-2337
18. Tan T.M.C., and Ting R.C.Y. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res. 55 (1995) 4599-4605
19. Kucharczuk J.C., Raper S., Elshami A.A., Amin K.M., Sterman D.H., Wheeldon E.B., et al. Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates. Hum. Gene Ther. 7 (1996) 2225-2233
20. Mitchell M.F., Hamada K., Sastry J., Sarkar A., Tortolero-Luna G., Wharton J.T., et al. Transgene expression in the rhesus cervix mediated by an adenovirus expressing beta-galactosidase. Am. J. Obstet. Gynecol. 174 (1996) 1094-1101
21. Lu C.Y., Giordano F.J., Rogers K.C., and Rothman A. Adenovirus-mediated increase of exogenous and inhibition of endogenous fosB gene expression in cultured pulmonary arterial smooth muscle cells. J. Mol. Cell. Cardiol. 28 (1996) 1703-1713
22. Yamanishi Y., Maeda H., Hiyama K., Ishioka S., and Yamakido M. Specific growth inhibition of small-cell lung cancer cells by adenovirus vector expressing antisense c-kit transcripts. Jpn. J. Cancer Res. 87 (1996) 534-542
23. Alemany R., Ruan S.B., Kataoka M., Koch P.E., Mukhopadhyay T., Cristiano R.J., et al. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells. Cancer Gene Ther. 3 (1996) 296-301
24. Lee C.T., Wu S., Gabrilovich D., Chen H., Nadaf-Rahrov S., Ciernik I.F., et al. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res. 56 (1996) 3038-3041
25. Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., and Howley P.M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119 (1985) 361-366
26. Hamada K., Zhang W.W., Alemany R., Roth J.A., Wolf J., and Mitchell M.F. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gynecol. Oncol. 60 (1996) 373-379
27. Hamada K., Alemany R., Zhang W.W., Hittelman W.N., Lotan R., Roth J.A., et al. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res. 56 (1996) 3047-3054
28. Andreeff M., Darzynkiewicz Z., Sharpless T.K., Clarkson B.D., and Melamed M.R. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55 (1980) 282-293
29. Zhang W.W., Fang X., Mazur W., French B.A., Georges R.N., and Roth J.A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1 (1994) 4-15
30. Hu G., Liu W., Hanania E.G., Fu S., Wang T., and Deisseroth A.B. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther. 2 (1995) 19-32
31. Tan T.M.C., Gloss B., Bernard H.-U., and Ting R.C.Y. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. J. Gen. Virol. 7 (1994) 2663-2670
32. Niu X.-Y., Peng Z.-L., Duan W.Q., Wang H., and Wang P. Inhibition of HPV16 E6 oncogene expression by RNA interference in vitro and in vivo. Int. J. Gynecol. Cancer 16 (2006) 743-751
33. Schneider-Gädicke A., and Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5 (1986) 2285-2292
34. Shirasawa H., Tanzawa H., Matsunaga T., and Shimizu B. Quantitative detection of spliced E6-E7 transcripts of human papillomavirus type 16 in cervical premalignant lesions. Virology 184 (1991) 795-798
35. Chen Z., Kamath P., Zhang S., Weil M.M., and Shillitoe E.J. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18. Cancer Gene Ther. 2 (1995) 263-271
36. Diller L., Kassel J., Nelson C.E., Gryka M.A., Litwak G., Gebhardt M., et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10 (1990) 5772-5781
37. El-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 (1994) 1169-1174
38. Dyson N., Howley P., Münger K., and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989) 934-937
39. Zerfass K., Schulze A., Spitkovsky D., Friedman V., Henglein B., and Jansen-Dürr P. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69 (1995) 6389-6399
40. Storey A., Massimi P., Dawson K., and Banks L. Conditional Immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53. Oncogene 11 (1995) 653-661
41. Chen J.J., Reid C.E., Band V., and Androphy E.J. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269 (1995) 529-531